File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Article: The use of induced pluripotent stem cells for disease modeling: what are the promises and hurdles?

TitleThe use of induced pluripotent stem cells for disease modeling: what are the promises and hurdles?
Authors
Issue Date2012
PublisherElsevier Ltd, Trends Journals. The Journal's web site is located at http://www.elsevier.com/locate/ddmod
Citation
Drug Discovery Today: Disease Models, 2012, v. 9 n. 4, p. e143–e145 How to Cite?
Persistent Identifierhttp://hdl.handle.net/10722/143055
ISSN
2020 SCImago Journal Rankings: 0.268

 

DC FieldValueLanguage
dc.contributor.authorLi, RAen_US
dc.date.accessioned2011-10-28T03:05:34Z-
dc.date.available2011-10-28T03:05:34Z-
dc.date.issued2012en_US
dc.identifier.citationDrug Discovery Today: Disease Models, 2012, v. 9 n. 4, p. e143–e145-
dc.identifier.issn1740-6757-
dc.identifier.urihttp://hdl.handle.net/10722/143055-
dc.languageengen_US
dc.publisherElsevier Ltd, Trends Journals. The Journal's web site is located at http://www.elsevier.com/locate/ddmoden_US
dc.relation.ispartofDrug Discovery Today: Disease Models-
dc.titleThe use of induced pluripotent stem cells for disease modeling: what are the promises and hurdles?en_US
dc.typeArticleen_US
dc.identifier.emailLi, RA: ronaldli@hkucc.hku.hken_US
dc.identifier.authorityLi, RA=rp01352en_US
dc.identifier.doi10.1016/j.ddmod.2012.10.001-
dc.identifier.scopuseid_2-s2.0-84876693020-
dc.identifier.hkuros197126en_US
dc.identifier.hkuros219950-
dc.identifier.volume9-
dc.identifier.issue4-
dc.identifier.spagee143-
dc.identifier.epagee145-
dc.publisher.placeUnited Kingdom-
dc.identifier.issnl1740-6757-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats